Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Harrow Health ( (HROW) ) has provided an announcement.
On June 18, 2025, Harrow Health held its Annual Meeting of Stockholders, where all matters submitted for a vote were approved. The meeting included the election of four directors, approval of the 2025 Incentive Stock and Awards Plan, ratification of Crowe LLP as auditors, and advisory votes on executive compensation and its frequency.
The most recent analyst rating on (HROW) stock is a Buy with a $57.00 price target. To see the full list of analyst forecasts on Harrow Health stock, see the HROW Stock Forecast page.
Spark’s Take on HROW Stock
According to Spark, TipRanks’ AI Analyst, HROW is a Neutral.
Harrow Health’s overall stock score is 60, reflecting strong revenue growth and positive technical momentum. However, significant profitability and leverage concerns weigh down the score. The earnings call provided a positive outlook, but valuation remains a key risk due to the company’s current unprofitability.
To see Spark’s full report on HROW stock, click here.
More about Harrow Health
Average Trading Volume: 502,531
Technical Sentiment Signal: Strong Buy
Current Market Cap: $1.16B
Find detailed analytics on HROW stock on TipRanks’ Stock Analysis page.